Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.48 USD | -1.78% | +1.44% | -10.30% |
Dec. 02 | HC Wainwright Adjusts NovoCure Price Target to $38 From $30, Maintains Buy Rating | MT |
Dec. 02 | NovoCure's Shares Rise as Pancreatic Cancer Trial Meets Primary Endpoint | MT |
- Stock Market
- Equities
- NVCR Stock
- News NovoCure Limited
- Transcripts